This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 18 and 45
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This study will determine definitive bioequivalence of the United States (U.S.) and United Kingdom (UK) formulations of fenofibrate following administration of single doses in healthy adult subjects.

Provided treatments

  • Drug: fenofibrate (U.S. formulation)
  • Drug: fenofibrate (UK formulation)
Tris trial is registered with FDA with number: NCT00928694. The sponsor of the trial is Merck Sharp & Dohme Corp. and it is looking for 14 volunteers for the current phase.
Official trial title:
An Open-Label, Randomized, 2-Period, Crossover Study to Determine Definitive Bioequivalence After Administration of Single 160 mg Doses of the U.S. and UK Formulations of Fenofibrate in Healthy Adult Subjects